Objective:To investigate the clinical efficacy and effects on hemorheology of acupuncture therapy combined with gaba-pentin in the treatment of patients with tension headache. Methods:Totally 92 cases of patients with tension headache were randomly divided into the observation group (n=46) and the control group (n=46) according to the random number table. The control group was given gabapentin, while the observation group was treated with acupuncture therapy on the basis of treatment in the control group. The treatment course was 4 weeks. The clinical efficacy, changes of the headache indices, VAS score and hemorheology levels before and after the treatments in the two groups were compared, and the incidence of adverse reactions was observed as well. Results:The to-tal effective rate of the observation group (93. 48%) was significantly higher than that of the control group (73. 91%, P<0. 05). Af-ter the treatment, the headache indices in both groups significantly decreased (P<0. 05), and the decrease in the observation group was more significant than that in the control group (P<0. 05). The VAS scores in both groups significantly decreased after the treat-ment (P<0. 05), and the decrease in the observation group was more significant than that in the control group (P<0. 05). The plas-ma viscosity, hematocrit and platelet aggregation rate in both groups significantly decreased after the treatment (P<0. 05), and the decrease in the observation group was more notable than that in the control group (P<0. 05). No severe adverse reactions were shown in both groups during the treatment course. Conclusion: Acupuncture therapy combined with gabapentin in the treatment of patients with tension headache shows striking effects, which can improve hemorheology with promising safety and deserves further studies.

Objective To investigate the clinical efficacy of ginkgo leaf tablets in patients with forgotten-type mild cognitive impairment (aMCI) and its effect on soluble glycosylated terminal product receptor (sRAGE) and soluble low-density lipoprotein receptor-associated protein 1 (sLRP-1).Methods A total of 124 patients with aMCI were divided into observation group (n =62) and control group (n =62),treated by nimodipine tablets (30 mg) three times a day,ginkgo leaf tablets for 3 times a day,respectively.The changes of MoCA score,levels of sRAGE,sLRP-1 and the occurrence of adverse reactions before and after treatment were compared between the two groups.Results The scores of MoCA were improved in both groups after treatment,and the observation group improved more after treatment,and the differences were statistically significant (P ＜ 0.0 5).There was no significant difference in plasma sRAGE and sLRP-1 levels between the two groups (P ＞ 0.05),but the plasma sRAGE increased and the sLRP-1 level decreased after treatment in two groups (P ＜ 0.05).Plasma sRAGE was higher in the treatment group than that in the control group,while the sLRP-1 level was lower than that in the control group (P ＜0.05).Conclusion Ginkgo leaf tablets have a significant clinical effect for aMCI patients,which can increase level of plasma sRAGE and decrease sLRP-1.

Objective To explore the effect of comprehensive nursing intervention on cognitive function,mental state and the quality of life in patients with Parkinson's disease.Methods Forty patients with Parkinson's disease treated in our hospital were randomly divided into control group and intervention group.The control group was treated with conventional drugs,and the intervention group was given comprehensive nursing intervention on the basis of conventional drug therapy for 6 months.Results The scores of cognitive function,mental state and the quality of life in intervention group were significantly better in the nursing group than control group (P ＜ 0.05).Conclusion Comprehensive nursing intervention has better efficacy,which can not only improve cognitive function,regulate the mental state and improve the quality of life,but also can greatly improve the negative emotions of patients with Parkinson's disease.

Objective To investigate the clinical efficacy of ginkgo leaf tablets in patients with forgotten-type mild cognitive impairment (aMCI) and its effect on soluble glycosylated terminal product receptor (sRAGE) and soluble low-density lipoprotein receptor-associated protein 1 (sLRP-1).Methods A total of 124 patients with aMCI were divided into observation group (n =62) and control group (n =62),treated by nimodipine tablets (30 mg) three times a day,ginkgo leaf tablets for 3 times a day,respectively.The changes of MoCA score,levels of sRAGE,sLRP-1 and the occurrence of adverse reactions before and after treatment were compared between the two groups.Results The scores of MoCA were improved in both groups after treatment,and the observation group improved more after treatment,and the differences were statistically significant (P ＜ 0.0 5).There was no significant difference in plasma sRAGE and sLRP-1 levels between the two groups (P ＞ 0.05),but the plasma sRAGE increased and the sLRP-1 level decreased after treatment in two groups (P ＜ 0.05).Plasma sRAGE was higher in the treatment group than that in the control group,while the sLRP-1 level was lower than that in the control group (P ＜0.05).Conclusion Ginkgo leaf tablets have a significant clinical effect for aMCI patients,which can increase level of plasma sRAGE and decrease sLRP-1.

Objective To explore the effect of comprehensive nursing intervention on cognitive function,mental state and the quality of life in patients with Parkinson's disease.Methods Forty patients with Parkinson's disease treated in our hospital were randomly divided into control group and intervention group.The control group was treated with conventional drugs,and the intervention group was given comprehensive nursing intervention on the basis of conventional drug therapy for 6 months.Results The scores of cognitive function,mental state and the quality of life in intervention group were significantly better in the nursing group than control group (P ＜ 0.05).Conclusion Comprehensive nursing intervention has better efficacy,which can not only improve cognitive function,regulate the mental state and improve the quality of life,but also can greatly improve the negative emotions of patients with Parkinson's disease.

Our group sought to determine the global status of T. gondii infection and to evaluate any continental and geographical trends by systematically examining the currently available epidemiological data on the prevalence of T. gondii infection. A comprehensive literature search was conducted from 10 electronic databases (Google Scholar, Science Direct, Embase, PubMed, PLOS ONE, Web of Knowledge, SciELO, MyAIS, Free Medical Journals, and Scopus) without date or language restrictions. Specific medical subject heading terms were used to search for human T. gondii seroprevalence studies that recruited subjects from general apparently healthy populations. The data were collated and analysed for both continental and global trends. The search identified 152 published studies that examined a total of 648,010 subjects. From these, 166,255 were seropositive for T. gondii infection indicating an average global seroprevalence rate of 25.7% (95% CI: 25.6 – 25.8%). The overall range of seroprevalence was determined to be 0.5 – 87.7%. African countries had the highest average seroprevalence rate of 61.4%, followed by Oceania with 38.5%, South America with 31.2%, Europe with 29.6%, USA/Canada with 17.5%, and Asia with 16.4%. Numerous environmental and human factors affect the differences in T. gondii seroprevalence rates observed between the various countries and continents. Monitoring the source and transmission may assist public health authorities to clarify the risk factors involved, as well as focus on implementing optimal state-specific health policies targeting T. gondii transmission control.

Integrating evidence from animal experiments is a critical component of biomedical research, providing essential prior information for in-depth investigations of disease mechanisms and new drug development. Animal models have played an irreplaceable role in simulating human diseases. However, the integration of evidence from animal experiments has faced numerous challenges, including insufficient emphasis, significant heterogeneity in study designs, high publication bias, and discrepancies with clinical research practices. This paper first identifies existing issues in the original research evidence from animal experiments, such as the selection and applicability of animal models, considerations in the design of experimental studies, and factors influencing the translation of animal experimental evidence. It then discusses various methods for integrating this evidence, including systematic review and meta-analysis, overview of systematic review/umbrella review, scoping review, and evidence mapping, while highlighting recent advancements in their application. Finally, the paper addresses the main challenges currently encountered in the integration of evidence from animal experiments and proposes targeted improvement strategies aimed at enhancing the efficiency of translating research outcomes into clinical practice and promoting the advancement of evidence-based medicine. By continuously optimizing original experimental research protocols and evidence integration practices, this work aims to establish a more efficient and scientific environment for the synthesis of evidence from animal experiments, ultimately contributing to clinical trials and human health.